Trial Profile
Dichotic Listening as a Predictor of Placebo and Medication Response in Depression
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 17 May 2019
Price :
$35
*
At a glance
- Drugs Fluoxetine (Primary) ; Imipramine
- Indications Depressive disorders; Dysthymic disorder; Major depressive disorder
- Focus Therapeutic Use
- 03 May 2012 New trial record